CentroDerm GmbH

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)1 trial
• Psoriasis1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Amgen Inc.1 trial
• Bristol-Myers Squibb1 trial

Closed trials

• Completed

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· Phase 3· Amgen Inc.· Source

• Completed

  Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

  NCT04036435· Phase 3· Bristol-Myers Squibb· Source